GlaxoSmithKline Pharmaceuticals Limited GlaxoSmithKline Pharmaceuticals Limited

GlaxoSmithKline Pharmaceuticals Limited

GLAXO

Hisse Senetlerindeki Sıralama #3781
GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise,... GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise, engages in the research, development, production, and global distribution of pharmaceutical drugs and vaccines. Its extensive product range encompasses both prescription and over-the-counter medications addressing diverse therapeutic areas such as anti-infectives, respiratory ailments, dermatology, nutritional deficiencies, gastrointestinal issues, and rare conditions. The company additionally provides consumer healthcare solutions. Prominent brands within its portfolio include Augmentin, Calpol, Ceftum, Eltroxin, Neosporin, Betnovate, Infanrix Hexa, Synflorix, and Boostrix, among numerous others. Founded in 1924 and headquartered in Mumbai, India, the company adopted its current name in 2001, having previously operated as SmithKline Beecham Pharmaceuticals India Ltd.
Hisse Fiyatı
$25.73
Piyasa Değeri
$4.36B
Değişim (1 gün)
-5.33%
Değişim (1 yıl)
-17.92%
Ülke
IN
Ticaret GlaxoSmithKline Pharmaceuticals Limited (GLAXO)

Kategori

Healthcare
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $28.33 - 2026-10-01

Gün sonu en düşük fiyat: $7.46 - 1999-01-01
GlaxoSmithKline Pharmaceuticals Limited için hisse fiyatı geçmişi: 1999 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) -0.80%
2025 3.53%
2024 30.13%
2023 28.84%
2022 -31.26%
2021 11.05%
2020 -8.11%
2019 15.01%
2018 5.68%
2017 -5.61%
2016 -18.58%
2015 0.11%
2014 11.37%
2013 16.93%
2012 5.11%
2011 -25.99%
2010 39.42%
2009 47.96%
2008 -8.92%
2007 -0.02%
2006 7.37%
2005 41.03%
2004 38.71%
2003 85.99%
2002 3.08%
2001 -33.62%
2000 -42.61%
1999 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$1.32K 61.95%
US
$264.92 37.31%
US
$284.94 24.60%
US
$152.76 74.36%
US
$482.50 30.89%
CH